PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
21-Jan-2021 Creative Diagnostics Announces SARS-CoV-2 Antibody Pairs for Rapid COVID-19 Antigen Assays Creative Diagnostics
20-Jan-2021 Amryt Receives Reimbursement Approval from NICE for Myalepta® (metreleptin) in England and Wales Amryt
20-Jan-2021 Evelo Biosciences Reports New Positive Confirmatory Data from Phase 1b Trial of EDP1815 in Atopic Dermatitis Evelo Biosciences
20-Jan-2021 OncoHost Secures $8 Million Series B Funding Round to Advance its AI-Powered Precision Oncology Platform OncoHost
20-Jan-2021 IVD Market: In-Depth Analysis of COVID-19 Impact on The Global Industry Worth $77.9 billion Markets and Markets
20-Jan-2021 Microlight3D prints tiniest Statue of Liberty using new 3D microprinting feature Andrew Lloyd Associates
20-Jan-2021 Enalare Therapeutics Appoints Mark Coleman M.D. to Its Board of Directors Enalare Therapeutics
19-Jan-2021 ConserV Bioscience and Lawrence Livermore National Laboratory to Collaborate on Development of Broad-spectrum Coronavirus Vaccine ConserV Bioscience
19-Jan-2021 Ixaka (formerly Rexgenero) launches as an integrated cell and gene therapy company Ixaka Ltd
19-Jan-2021 Transgene and BioInvent receive approval from ANSM to proceed with Phase I/IIa trial of anti-CTLA4-armed oncolytic virus BT-001 in solid tumors Transgene
19-Jan-2021 Growing Adoption of Bio decontamination Products and Services by Pharmaceutical and Biotechnology Industries MarketsandMarkets
19-Jan-2021 Endo Tools Therapeutics secures €8 million ($9.5M) in Series D funding led by White Fund Andrew Lloyd Associates
19-Jan-2021 T-knife Announces Appointment of Thomas M. Soloway as Chief Executive Officer and Camille A. Landis as Chief Business Officer & Chief Financial Officer T-knife GmbH
18-Jan-2021 ONK Therapeutics Appoints Mary Reilly as Chief Operating Officer ONK Therapeutics
18-Jan-2021 Creative BioMart Microbe Provides One-stop Microbial Protein Expression Services Creative BioMart
17-Jan-2021 Registration Opens for SMi’s 5th Annual Highly Potent Active Pharmaceutical Ingredients Conference (HPAPi) SMi Group
14-Jan-2021 Registration Opens for SMi’s 21st Annual Pain Therapeutics Virtual Conference SMi Group
14-Jan-2021 Bone Therapeutics and Rigenerand sign partnership for cell therapy process development Bone Therapeutics
14-Jan-2021 Syntekabio Signs Joint Development Agreement with Hanmi Science Syntekabio,Inc.
13-Jan-2021 RheinCell Therapeutics Achieves Milestone GMP Certification to Manufacture Cord Blood-Derived iPSCs for Safe and Compliant Cell Therapies RheinCell Therapeutics